Get the Stockscreener App
2.84
2.41%
-0.07
After Hours:
2.81
-0.03
-1.06%
Entera Bio Ltd stock is traded at $2.84, with a volume of 184.42K.
It is down -2.41% in the last 24 hours and up +49.47% over the past month.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
See More
Previous Close:
$2.91
Open:
$2.87
24h Volume:
184.42K
Relative Volume:
1.28
Market Cap:
$129.68M
Revenue:
$134.00K
Net Income/Loss:
$-9.93M
P/E Ratio:
-8.3529
EPS:
-0.34
Net Cash Flow:
$-6.72M
1W Performance:
+21.89%
1M Performance:
+49.47%
6M Performance:
+20.34%
1Y Performance:
+57.78%
1-Day Range:
$2.77
$2.97
1-Week Range:
$2.272
$2.97
52-Week Range:
$1.5006
$2.97
Entera Bio Ltd Stock (ENTX) Company Profile
Name
Entera Bio Ltd
Sector
Industry
Phone
972-2-532-7151
Address
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Compare ENTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
2.84 | 132.88M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-22-21 | Initiated | Aegis Capital | Buy |
Entera Bio Ltd Stock (ENTX) Latest News
Is now a turning point for Entera Bio Ltd.Portfolio Gains Summary & Technical Pattern Alert System - newser.com
Can Entera Bio Ltd. stock deliver surprise earnings beatJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
Real time scanner hits for Entera Bio Ltd. explainedTrade Ideas & AI Optimized Trading Strategy Guides - newser.com
How to integrate Entera Bio Ltd. into portfolio analysis toolsJuly 2025 Institutional & Safe Investment Capital Preservation Plans - newser.com
What indicators show strength in Entera Bio Ltd.Portfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Why Entera Bio Ltd. stock remains undervaluedPortfolio Update Summary & High Conviction Buy Zone Alerts - newser.com
What Fibonacci levels say about Entera Bio Ltd. reboundInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
Chart based analysis of Entera Bio Ltd. trendsJuly 2025 Decliners & Verified Short-Term Plans - newser.com
How Entera Bio Ltd. stock reacts to inflationary pressuresMarket Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
Why Entera Bio Ltd. (5DT) stock appeals to dividend investorsTrade Risk Report & Risk Controlled Daily Plans - newser.com
How to build a dashboard for Entera Bio Ltd. stockQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com
Backtesting results for Entera Bio Ltd. trading strategies2025 Year in Review & Verified Stock Trade Ideas - newser.com
Technical analysis overview for Entera Bio Ltd. stockPortfolio Risk Summary & Technical Pattern Alert System - newser.com
Can Entera Bio Ltd. stock surprise with earnings upside2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Live market analysis of Entera Bio Ltd.Weekly Trade Review & AI Driven Price Predictions - newser.com
Developing predictive dashboards with Entera Bio Ltd. dataTrade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
Does Entera Bio Ltd. qualify in momentum factor screeningTrade Risk Assessment & Growth Oriented Trading Recommendations - newser.com
Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Grows By 86.7% - MarketBeat
Is Entera Bio Ltd. stock cheap at current valuationJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
Can Entera Bio Ltd. (5DT) stock sustain institutional flowsJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
What to do if you’re stuck in Entera Bio Ltd.July 2025 Pullbacks & Weekly Chart Analysis and Guides - newser.com
Entera Bio (NASDAQ:ENTX) Stock Price Up 3.3%Time to Buy? - MarketBeat
Is Entera Bio Ltd. forming a reversal patternSell Signal & High Return Stock Watch Alerts - newser.com
How rising interest rates impact Entera Bio Ltd. stock2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Will Entera Bio Ltd. outperform the marketMarket Risk Report & Daily Stock Momentum Reports - newser.com
Entera Bio Ltd Stock (ENTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):